Johansson J, Curstedt T, Robertson B
Dept of Chemistry 1, Karolinska Institutet, Stockholm, Sweden.
Eur Respir J. 1994 Feb;7(2):372-91. doi: 10.1183/09031936.94.07020372.
The structural and functional integrity of pulmonary surfactant depends on several specific proteins. Two of these, SP-A and SP-D, are large and water-soluble, while SP-B and SP-C are small and very hydrophobic. SP-A is an 18-mer of 26 kDa polypeptide chains and contains N-linked oligosaccharides. Structurally, it can be characterized as a collagen/lectin hybrid. Together with SP-B, SP-A is required for conversion of secreted endogenous surfactant to tubular myelin in the alveolar lining. It also regulates surfactant secretion and reuptake of surfactant lipids by type II cells; these functions are probably receptor mediated. SP-D, a 12-mer of 39 kDa polypeptide chains, is a collagenous glycoprotein with structural similarities to C-type lectins. Both SP-A and SP-D stimulate alveolar macrophages. SP-B is a 79-residue polypeptide that contains three intrachain disulphide bridges. It exists mainly as a homodimer, which is strongly positively charged and may selectively remove anionic and unsaturated lipid species from the alveolar surface film, thereby increasing surface pressure. SP-C is a mainly alpha-helical, extraordinarily hydrophobic polypeptide containing 35 amino acid residues and covalently linked palmitoyl groups. Its alpha-helical portion is inserted into surfactant lipid bilayers. SP-C accelerates the adsorption of lipid bilayers to an interfacial monolayer. In babies with respiratory distress syndrome, the clinical response to treatment with surfactant containing SP-B and SP-C is much faster than in babies treated with protein-free synthetic surfactant. We speculate that, in the near future, surfactant preparations based on recombinant hydrophobic proteins will be available for clinical use.
肺表面活性物质的结构和功能完整性取决于几种特定的蛋白质。其中两种,即SP - A和SP - D,分子大且水溶性强,而SP - B和SP - C则分子小且疏水性极强。SP - A是由26 kDa多肽链组成的18聚体,含有N - 连接寡糖。在结构上,它可被表征为胶原蛋白/凝集素杂种。与SP - B一起,SP - A是肺泡内衬中分泌的内源性表面活性物质转化为管状髓鞘所必需的。它还调节表面活性物质的分泌以及II型细胞对表面活性物质脂质的再摄取;这些功能可能是由受体介导的。SP - D是由39 kDa多肽链组成的12聚体,是一种与C型凝集素结构相似的胶原糖蛋白。SP - A和SP - D都能刺激肺泡巨噬细胞。SP - B是一种含有三个链内二硫键的79个残基的多肽。它主要以同二聚体形式存在,带强正电荷,可能选择性地从肺泡表面膜中去除阴离子和不饱和脂质种类,从而增加表面压力。SP - C主要是α - 螺旋结构,是一种含有35个氨基酸残基且共价连接棕榈酰基团的极度疏水的多肽。其α - 螺旋部分插入表面活性物质脂质双层中。SP - C加速脂质双层向界面单层的吸附。在患有呼吸窘迫综合征的婴儿中,使用含SP - B和SP - C的表面活性物质治疗的临床反应比使用无蛋白合成表面活性物质治疗的婴儿要快得多。我们推测,在不久的将来,基于重组疏水蛋白的表面活性物质制剂将可用于临床。